News Search Results
Sep 25, 2025, 08:00 ET Avant Technologies, Inc. Bolsters Strategic Vision with Targeted Biotech Partnerships for Innovative Cell-Based Therapies
conditions. In alignment with this refined mission, the company has applied for a corporate name change to better reflect its focus on pioneering biotechnology collaborations aimed at enhancing better health and longevity.
More news about: Avant Technologies Inc.
Sep 25, 2025, 08:00 ET National Ataxia Foundation Partners with Biogen to Bring Bill Nye "the Science Guy" Back To the Lab With New Series About Friedreich Ataxia
educational campaign to raise awareness and understanding of Friedreich ataxia (FA), a rare, genetic disease. The campaign, in partnership with leading biotechnology company, Biogen Inc., features a four-part series starring Bill Nye "the Science Guy," who uses his iconic teaching
More news about: National Ataxia Foundation
Sep 25, 2025, 07:00 ET Leap Therapeutics to Present Final Clinical Data from Part B of the DeFianCe Study at the ESMO Congress 2025
Mass., Sept. 25, 2025 /PRNewswire/ -- Leap Therapeutics, Inc. (Nasdaq: LPTX), a biotechnology company focused on developing targeted and immuno-oncology therapeutics, today announced it will present the final clinical results from Part B
More news about: Leap Therapeutics, Inc.
Sep 25, 2025, 06:30 ET Immunic Presented Key Vidofludimus Calcium Data at the 41st Congress of ECTRIMS, Highlighting Its Potential in Multiple Sclerosis
Immunic, Inc. (Nasdaq: IMUX), a biotechnology company developing a clinical pipeline of orally administered, small molecule therapies for chronic inflammatory and autoimmune diseases, today
More news about: Immunic, Inc.
Sep 25, 2025, 03:35 ET ZINZINO AB (PUBL.): ZINZINO ACQUIRES TRUVY TO INCREASE DISTRIBUTION CAPACITY IN NORTH AMERICA, LATIN AMERICA, AND SOUTH KOREA
strategically important step in Zinzino's growth plans, which focus on improving personal health and well-being on a global level with innovative biotechnology and a groundbreaking product portfolio marketed through direct sales. Truvy is a global direct sales company in the health segment, operating
More news about: Zinzino
Sep 25, 2025, 03:30 ET Evonik and AMSilk extend partnership for sustainable biotech silk materials
automotive interiors. "Our collaboration with AMSilk is a powerful example of how together we can shape the future of materials through biotechnology. By scaling production of sustainable silk proteins, we are not only expanding our portfolio of precision biosolutions — we are creating solutions
More news about: AMSilk
Sep 25, 2025, 03:30 ET Lonza's Synaffix Collaborates with Qurient Therapeutics to Enable Development of Dual-Payload ADC
forward to exploring those possibilities in the future." Notes to Editors About Synaffix Synaffix B.V. is a biotechnology company that enables ADC product candidates using its clinical-stage, site-specific ADC technology platform based on GlycoConnect®, HydraSpace®
More news about: Synaffix
Sep 25, 2025, 03:30 ET ZINZINO AB (PUBL.): ZINZINO ACQUIRES TRUVY TO INCREASE DISTRIBUTION CAPACITY IN NORTH AMERICA, LATIN AMERICA, AND SOUTH KOREA
strategically important step in Zinzino's growth plans, which focus on improving personal health and well-being on a global level with innovative biotechnology and a groundbreaking product portfolio marketed through direct sales. Truvy is a global direct sales company in the health segment, operating
More news about: Zinzino
Sep 25, 2025, 03:10 ET Aker participates in Nscale's USD 1.1 billion Series B funding round
Norway. Founded in 1841, Aker builds and develops leading companies across energy, industrial software, renewables, and marine biotechnology. As the largest shareholder in several listed and privately held companies, Aker combines deep industrial expertise, financial strength, and capital
More news about: Aker ASA
Sep 24, 2025, 20:34 ET Jasper Therapeutics, Inc. Class Action Alert: Shareholder Rights Law Firm Robbins LLP Reminds Investors of the Lead Plaintiff Deadline in the JSPR Class Action Lawsuit
JSPR) securities between November 30, 2023 and July 3, 2025. Jasper, a clinical-stage biotechnology company, focuses on developing therapeutics targeting mast cell driven diseases such as Chronic Spontaneous Urticaria ("CSU"), Chronic Inducible
More news about: Robbins LLP
Sep 24, 2025, 14:32 ET ADVANCION PUBLISHES 2024 CORPORATE SUSTAINABILITY REPORT
baculovirus expression vector system (BEVS) platform that enhances productivity for advanced therapies—demonstrating the Company's role in enabling biotechnology innovation.Safety leadership – For the second consecutive year, Advancion's Sterlington, Louisiana,
More news about: Advancion Corporation
Sep 24, 2025, 13:42 ET ADVANCION PUBLISHES 2024 CORPORATE SUSTAINABILITY REPORT
baculovirus expression vector system (BEVS) platform that enhances productivity for advanced therapies—demonstrating the Company's role in enabling biotechnology innovation.Safety leadership – For the second consecutive year, Advancion's Sterlington, Louisiana,
More news about: Advancion Corporation
Sep 24, 2025, 10:30 ET Drilling Machine Market is Projected to Reach US$31.72 Billion by 2031 at a CAGR of 6.15% | The Insight Partners
syndicated and consulting research services. We specialize in semiconductor and electronics, aerospace and defense, automotive and transportation, biotechnology, healthcare IT, manufacturing and construction, medical devices, technology, media and telecommunications, and chemicals and materials. Contact
More news about: The Insight Partners
Sep 24, 2025, 10:30 ET Robo Advisor Market Projected to Reach USD 3.2 Trillion by 2033, Growing at a Strong CAGR of 10.5% During 2026-2033 - Market Research Intellect
Thermostatic Baths Market is categorized based on Application (Pharmaceutical Laboratories, Chemical Research, Biotechnology, Food & Beverage Testing, Environmental Testing, Academic & Educational Labs, Clinical Diagnostics) and Type (Heated Circulating Baths,
More news about: Market Research Intellect
Sep 24, 2025, 10:28 ET Global Generative AI Market to Surge from USD 49.3 Billion in 2024 to USD 2427.19 Billion by 2035, Growing at a CAGR 42.5% | Transforming Enterprise & Creative Workflows
market research reports and actionable intelligence across healthcare, biotechnology, and advanced cell therapies. Our globally recognized insights empower stakeholders to make informed decisions, anticipate trends, and capitalize
More news about: Vantage Market Research
Sep 24, 2025, 10:01 ET Electronic Health Record Market Is Expected To Reach US$79.42 Billion By 2031 At CAGR of 10.3% | The Insight Partners
syndicated and consulting research services. We specialize in semiconductor and electronics, aerospace and defense, automotive and transportation, biotechnology, healthcare IT, manufacturing and construction, medical devices, technology, media and telecommunications, and chemicals and materials. Contact
More news about: The Insight Partners
Sep 24, 2025, 10:00 ET FYR Closes $8 Million Financing to Advance Blood-Based Biomarkers Across Oncology and Neuroscience
FYR Bio, a biotechnology company leveraging extracellular vesicles (EVs) to create an end-to-end solution for new precision medicine tools, today announced it has closed
More news about: FYR Diagnostics
Sep 24, 2025, 09:31 ET ResVita Bio Announces Positive FDA Pre-IND Meeting, Advancing RVB-003 Toward IND Filing for Netherton Syndrome in Early 2026
BERKELEY, Calif., Sept. 24, 2025 /PRNewswire/ -- ResVita Bio, a biotechnology company pioneering continuous protein therapy for skin diseases, today announced the successful completion of a face-to-face Pre-Investigational
More news about: ResVita Bio
Sep 24, 2025, 09:07 ET Nutrafol Becomes First and Only Hair Growth Supplement Brand to Earn NSF Certified for Sport®, Enters Multi-Year Partnership with Major League Baseball
cutting edge of innovation, Nutrafol's team of doctors and researchers continue to seek out scientific advancements at the forefront of genetics, biotechnology, and anti-aging. Nutrafol has been adopted by more than 7,500 healthcare providers and professionals across the U.S. for its trusted, reliable results,
More news about: NUTRAFOL
Sep 24, 2025, 09:02 ET Immorta Bio Reports Preclinical Activity of Senolytic Immunotherapy SenoVax™ in a Chronic Traumatic Encephalopathy (CTE) Model
explore CTE and other neurodegenerative indications." About Immorta Bio Immorta Bio, Inc. is a longevity-focused biotechnology company developing personalized cellular and immune therapeutics, including SenoVax™ (senolytic immunotherapy) and StemCellRevivify™
More news about: Immorta Bio, Inc.
Sep 24, 2025, 09:00 ET Hood College Receives NSF Grant for Biotechnology Training Program
Biotechnology Training Program to be held in Hood's Bioscience Research and Education Center FREDERICK, Md., Sept. 24, 2025 /PRNewswire/
More news about: Hood College
Sep 24, 2025, 08:30 ET AI and Machine Learning Uses in Neuroscience Drug Discovery, Upcoming Webinar Hosted by Xtalks
the global life science, food, healthcare and medical device communities. Every year, thousands of industry practitioners (from pharmaceutical, biotechnology, food, healthcare and medical device companies, private & academic research institutions, healthcare centers, etc.) turn to Xtalks for access
More news about: Xtalks
Sep 24, 2025, 08:30 ET Clinical Data Analysis with Agents: Reliable Automation with Human Oversight, Upcoming Webinar Hosted by Xtalks
the global life science, food, healthcare and medical device communities. Every year, thousands of industry practitioners (from pharmaceutical, biotechnology, food, healthcare and medical device companies, private & academic research institutions, healthcare centers, etc.) turn to Xtalks for access
More news about: Xtalks
Sep 24, 2025, 08:00 ET Michroma and CJ CheilJedang Partner to Scale Commercial Production of Natural Colorants
2025 /PRNewswire/ -- Michroma, a biotech pioneer in sustainable natural colorants, and CJ CheilJedang (CJCJ), a global leader in food and biotechnology, today announced a strategic partnership to advance the commercial manufacturing of Michroma's innovative biotech-based colorants. This
More news about: Michroma
Sep 24, 2025, 08:00 ET Tapping LATAM's Untapped Patient Pool for Ophthalmology Trials, Upcoming Webinar Hosted by Xtalks
the global life science, food, healthcare and medical device communities. Every year, thousands of industry practitioners (from pharmaceutical, biotechnology, food, healthcare and medical device companies, private & academic research institutions, healthcare centers, etc.) turn to Xtalks for access
More news about: Xtalks